Recurrent bleeding duodenal and colonic ulcers due to post-transplant lymphoproliferative disorder

被引:0
作者
Mitsuhashi, Shuji [1 ]
Chalikonda, Divya [2 ]
Nazir, Bushra [3 ]
Agarwarl, Amit [2 ]
Coben, Robert [2 ]
机构
[1] Thomas Jefferson Univ Hosp, Dept Med, 833 Chestnut St Suite 220, Philadelphia, PA 19107 USA
[2] Thomas Jefferson Univ Hosp, Dept Med, Div Gastroenterol & Hepatol, Philadelphia, PA 19107 USA
[3] Thomas Jefferson Univ Hosp, Dept Pathol, Philadelphia, PA 19107 USA
关键词
Post-transplant lymphoproliferative disorder; Orthotopic heart transplant; Recurrent gastrointestinal bleeding; Epstein-Barr virus; Rituximab; DISEASE;
D O I
10.1007/s12328-022-01718-1
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Post-transplant lymphoproliferative disorder (PTLD) is a rare complication of solid organ transplantation as the result of immunosuppressant medications. Epstein-Barr virus (EBV) has been implicated in most of these cases, specifically with B-cell predominant lymphoma. This case report describes a 24-year-old female who presented with recurrent GI bleed within 6 months post-orthostatic heart transplant. Endoscopic evaluations including video capsule study, push enteroscopy, and colonoscopy revealed multiple ulcerated lesions in duodenum, jejunum, and colon secondary to Epstein-Barr Virus-associated monomorphic PTLD. Despite continuation of rituximab after discharge, she returned to the hospital for recurrent GI bleed requiring additional endoscopic intervention. PTLD is a devastating disease of the post-transplant population. Due to a high risk of recurrent GI bleeding, patients with PTLD may benefit from careful monitoring by gastroenterology as an outpatient with a low threshold for repeat endoscopic evaluation despite being on immunotherapy or chemotherapy.
引用
收藏
页码:39 / 42
页数:4
相关论文
共 14 条
[1]   Post-Transplant Lymphoproliferative Disease (PTLD): Risk Factors, Diagnosis, and Current Treatment Strategies [J].
Al-Mansour, Zeina ;
Nelson, Beverly P. ;
Evens, Andrew M. .
CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2013, 8 (03) :173-183
[2]  
Brahmbhatt Akshaar N, 2020, Radiol Case Rep, V15, P396, DOI [10.1016/j.radcr.2020.01.006, 10.1016/j.radcr.2020.01.006]
[3]  
Chia SC, 2008, SINGAP MED J, V49, pE117
[4]  
Gandhi S, 2020, Case Rep Transplant, V2020, P8247308, DOI [10.1155/2020/8247308, 10.1155/2020/8247308]
[5]   Epstein-Barr Virus Infection and Posttransplant Lymphoproliferative Disorder [J].
Green, M. ;
Michaels, M. G. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 :41-54
[6]   Post-transplantation lymphoproliferative disorder with gastrointestinal involvement [J].
Inayat, Faisal ;
Ul Hassan, Ghias ;
Tayyab, Ghias Un Nabi ;
Saif, Muhammad Wasif .
ANNALS OF GASTROENTEROLOGY, 2018, 31 (02) :248-251
[7]   Post-transplant lymphoproliferative disorder as a cause of oesophageal ulceration and stricture: case report and literature review [J].
Mukhtar, Mariam S. ;
Wolman, Stephen L. .
BMJ OPEN GASTROENTEROLOGY, 2021, 8 (01)
[8]   Early Onset Post-transplant Lymphoproliferative Disorder Presenting with Diarrhea Post-orthotopic Liver Transplant Treated Successfully with Single Rituximab Agent [J].
Patek, Bonnie ;
Strahotin, Cristina .
CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (11)
[9]   Epstein-Barr virus-related post-transplant lymphoproliferative disorder in solid organ transplant recipients [J].
San-Juan, R. ;
Comoli, P. ;
Caillard, S. ;
Moulin, B. ;
Hirsch, H. H. ;
Meylan, P. .
CLINICAL MICROBIOLOGY AND INFECTION, 2014, 20 :109-118
[10]   Epstein-Barr virus-associated post-transplant lymphoproliferative disorders: beyond chemotherapy treatment [J].
Shahid, Sanam ;
Prockop, Susan E. .
CANCER DRUG RESISTANCE, 2021, 4 (03) :646-664